Interventional versus conservative treatment for patients with unstable angina or non-ST-elevation myocardial infarction: the British Heart Foundation RITA 3 randomised trial. Randomized…
By Kaa Fox, P. Poole-Wilson, R. Henderson, T. Clayton, D. Chamberlain, T. Shaw, D. Wheatley, S. Pocock. The Lancet, 2002
904 citations recorded by the source corpus.
Subfields: Cardiology and Cardiovascular Medicine, Radiology, Nuclear Medicine and Imaging, Surgery
View Paper: https://www.semanticscholar.org/paper/700d153fd650ac58cfce359295e4d1e9b2ad35d7
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Cardiology and Cardiovascular Medicine
Citations in the corpus
- Coronary CT Angiography and 5‐Year Risk of Myocardial Infarction (2018, neutral): “Atypical angina 988/4142 (24) 486/2070 (23) 502/2072 (24)”
- ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention--summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to update the 2001 Guidelines for Percutaneous Coronary Intervention (2006, neutral): “Criteria regarding viable and high-risk myocardium have been deleted from this recommendation (30, 31).”
- 2014 AHA/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. (2014, background): “Small sample size, interventions were done in only one high volume tertiary center RITA -2, Fox et al, 2002 To compare interventional RCT 1,810 Intervention: 895 vs. Pts were eligible for inclusion if they had All those with probable evolving Pts assigned to the interventional treatment Pts…”
- 2014 AHA/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. (2014, neutral): “In initially stabilized patients, an ischemia-guided strategy may be considered for patients with NSTE-ACS (without serious comorbidities or contraindications to this approach) who have an elevated risk for clinical events (174,175,177).”